Acrivon Therapeutics, Inc. (ACRV)

NASDAQ: ACRV · Real-Time Price · USD

2.240

-0.280 (-11.11%)

At close: Mar 28, 2025, 4:00 PM

2.400

+0.160 (7.14%)

After-hours: Mar 28, 2025, 7:59 PM EDT

Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	39.82	36.02	29.52	99.6	1.58
Short-Term Investments	139.66	91.44	98.23	-	-
Cash & Short-Term Investments	179.48	127.46	127.75	99.6	1.58
Cash Growth	40.81%	-0.23%	28.26%	6192.04%	-
Prepaid Expenses	2.15	2.23	4.34	0.81	0.14
Total Current Assets	181.63	129.69	132.1	100.41	1.72
Property, Plant & Equipment	8.03	7.91	6.86	5.79	0.06
Long-Term Investments	5.09	-	41.88	-	-
Long-Term Deferred Charges	-	0.25	-	-	-
Other Long-Term Assets	1.85	0.41	0.39	0.39	0.41
Total Assets	196.59	138.27	181.23	106.59	2.19
Accounts Payable	0.76	5.05	0.9	0.96	0.14
Accrued Expenses	15.4	7.38	4.14	1.22	0.42
Short-Term Debt	-	-	-	-	0.06
Current Portion of Leases	1.06	0.88	0.73	0.66	-
Current Unearned Revenue	-	-	0.07	0.07	-
Other Current Liabilities	-	-	0.67	-	-
Total Current Liabilities	17.21	13.3	6.52	2.91	0.61
Long-Term Leases	2.59	3.77	4.24	4.96	-
Total Liabilities	19.8	17.07	10.75	7.88	0.61
Common Stock	0.03	0.02	0.02	0	0
Additional Paid-In Capital	373.28	237.68	226.58	1.05	0.21
Retained Earnings	-196.98	-116.42	-56.03	-24.87	-8.62
Comprehensive Income & Other	0.45	-0.08	-0.1	-	-
Total Common Equity	176.79	121.2	170.48	-23.81	-8.41
Shareholders' Equity	176.79	121.2	170.48	98.71	1.57
Total Liabilities & Equity	196.59	138.27	181.23	106.59	2.19
Total Debt	3.65	4.64	4.96	5.63	0.06
Net Cash (Debt)	175.84	122.81	122.79	93.98	1.53
Net Cash Growth	43.17%	0.02%	30.66%	6062.30%	-
Net Cash Per Share	5.20	5.56	29.79	53.90	1.06
Filing Date Shares Outstanding	31.35	22.64	21.92	1.77	1.43
Total Common Shares Outstanding	31.23	22.52	21.92	1.77	1.43
Working Capital	164.42	116.39	125.58	97.49	1.11
Book Value Per Share	5.66	5.38	7.78	-13.45	-5.87
Tangible Book Value	176.79	121.2	170.48	-23.81	-8.41
Tangible Book Value Per Share	5.66	5.38	7.78	-13.45	-5.87
Machinery	-	3.13	2.51	0.35	0.08
Construction In Progress	-	1.31	-	-	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q